Log in
Pharmacology · Drugs used for cerebral circulatory disorders

Ergot alkaloid derivatives

Nicergolinum

Ergot alkaloid derivatives represent a group of pharmacological compounds, the key representative of which is the synthetic drug nicergoline (Sermion). It is used to correct cerebral and peripheral circulation disorders due to its vasodilating properties.

DrugNicergoline (Sermion)
StructureBrominated nicotinic acid residue
MechanismAlpha-adrenoceptor blocker and myotropic antispasmodic
TargetCerebral arterioles and peripheral vessels
Effect on BPNo effect orally, decreases upon IV administration
3 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Chemical structure and pharmacokinetics

The sole main representative of the group under consideration is nicergoline. Structurally, the substance is a synthetic derivative of ergot alkaloids. A feature of its molecular structure is an attached brominated nicotinic acid residue.

The drug can be administered via various routes depending on the clinical situation:

  • Enterally (oral administration).
  • Parenterally (including intravenous administration).

Mechanism of pharmacological action

The pharmacological response of the body to drug administration is due to a combined mechanism, which includes two essential components:

  1. Alpha-adrenoblocking effect — consists in the targeted blockade of vasoconstrictor adrenoceptors.
  2. Direct myotropic effect — provides direct relaxation of the vascular wall smooth muscle (spasmolytic effect).
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Pharmacodynamic effects and hemodynamics

Due to the combination of receptor and myotropic properties, the drug has a pronounced effect on the vascular system. The main vascular targets are cerebral arterioles and peripheral vessels.

The systemic hemodynamic response manifests as follows:

  • Dilatation of cerebral arterioles.
  • Dilatation of the peripheral vascular bed.
  • Overall improvement of hemodynamics and blood supply in various vascular beds: cerebral, pulmonary, renal, and in the extremities.

Oral administration of the drug in therapeutic doses does not affect blood pressure. However, intravenous administration carries a risk of developing a hypotensive effect (decrease in BP).

Indications and adverse reactions

The presence of vasodilating properties determines the main clinical indications for prescribing the medicinal product:

  • Cerebral circulation disorders developing against the background of atherosclerosis or thromboembolism.
  • Peripheral circulation disorders.

During pharmacotherapy, adverse effects may develop:

  • Vestibular disorders in the form of dizziness.
  • Allergic and skin manifestations (pruritus).
  • Gastrointestinal disorders (dyspepsia).

Briefly: answers to topical questions

What other drugs belong to the ergot alkaloid derivatives group, besides nicergoline?

The group of ergot alkaloid derivatives includes various drugs used as vascular agents, medications affecting myometrial tone, and dopamine receptor agonists:

  • Ergometrine (ergometrinum) is an ergot alkaloid that increases myometrial tone.
  • Ergotamine (ergotaminum) is an ergot alkaloid.
  • Bromocriptine (bromocriptinum) is an ergot alkaloid derivative and a dopamine receptor agonist.
  • Pergolide (pergolidum) is an ergot alkaloid derivative and a dopamine receptor agonist.
  • Lisuride (lisuridum) is an ergot alkaloid.

With what receptor types, besides alpha-adrenoceptors, do ergot alkaloid derivatives interact?

Ergot alkaloid derivatives interact with dopamine receptors in addition to alpha-adrenoceptors. Specifically, drugs in this group such as bromocriptine and pergolide are direct dopamine receptor agonists, showing the highest activity at $D_2$-type receptors.

How to memorize

Nicergoline = bromine + nicotinic acid: blocks alpha-receptors, relaxes vascular smooth muscle, treats the brain and extremities, but drops blood pressure when given IV.

Class and exam questions

Which main representative belongs to ergot alkaloid derivatives in this topic?

The main representative is nicergoline (known under the trade name Sermion).

What are the features of the chemical structure of nicergoline?

It is a synthetic ergot alkaloid derivative that contains a brominated nicotinic acid residue.

Does the drug alter blood pressure when taken orally?

When administered orally in therapeutic doses, the drug does not affect blood pressure, whereas intravenous administration can cause a hypotensive effect.

Still have questions? Ask the AIThe AI tutor has reviewed the study material on "Ergot Alkaloid Derivatives" and will explain it in simple terms.

What else to study on this topic

  • Features of the alpha-adrenoceptor blocking activity of ergot derivatives
  • Comparison of the pharmacodynamics of myotropic antispasmodics and vasodilators
  • Pathogenesis of cerebrovascular disorders in atherosclerosis and thromboembolism
  • Differentiated approach to enteral and parenteral administration of vasoactive agents
  • Pharmacological correction of peripheral circulation disorders

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Comprehensive study guide on "Ergot Alkaloid Derivatives" and 5,304 other subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the section "Drugs used for cerebral circulatory disorders"

The entire section "Drugs used for cerebral circulatory disorders"

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.